Condition
High Altitude Effects
Total Trials
4
Recruiting
3
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
P 4 (2)
Trial Status
Recruiting3
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07193771Recruiting
Altitude and Outcomes in Pediatric ARDS: A Multicenter Study
NCT07118462Phase 4RecruitingPrimary
HighCycle Study: Acetazolamide, High Altitude and Plasma Volume
NCT05769140RecruitingPrimary
Measurement of Cardiopulmonary Variables After Acute Exposure to High Altitude
NCT05575180Phase 4CompletedPrimary
Effect of Acetazolamide and Methazolamide on Hypoxic Exercise Performance
Showing all 4 trials